Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Aug 13;20(8):515.
doi: 10.3390/md20080515.

Novel Labdane Diterpenes-Based Synthetic Derivatives: Identification of a Bifunctional Vasodilator That Inhibits CaV1.2 and Stimulates KCa1.1 Channels

Affiliations

Novel Labdane Diterpenes-Based Synthetic Derivatives: Identification of a Bifunctional Vasodilator That Inhibits CaV1.2 and Stimulates KCa1.1 Channels

Gabriele Carullo et al. Mar Drugs. .

Abstract

Sesquiterpenes such as leucodin and the labdane-type diterpene manool are natural compounds endowed with remarkably in vitro vasorelaxant and in vivo hypotensive activities. Given their structural similarity with the sesquiterpene lactone (+)-sclareolide, this molecule was selected as a scaffold to develop novel vasoactive agents. Functional, electrophysiology, and molecular dynamics studies were performed. The opening of the five-member lactone ring in the (+)-sclareolide provided a series of labdane-based small molecules, promoting a significant in vitro vasorelaxant effect. Electrophysiology data identified 7 as a CaV1.2 channel blocker and a KCa1.1 channel stimulator. These activities were also confirmed in the intact vascular tissue. The significant antagonism caused by the CaV1.2 channel agonist Bay K 8644 suggested that 7 might interact with the dihydropyridine binding site. Docking and molecular dynamic simulations provided the molecular basis of the CaV1.2 channel blockade and KCa1.1 channel stimulation produced by 7. Finally, 7 reduced coronary perfusion pressure and heart rate, while prolonging conduction and refractoriness of the atrioventricular node, likely because of its Ca2+ antagonism. Taken together, these data indicate that the labdane scaffold represents a valuable starting point for the development of new vasorelaxant agents endowed with negative chronotropic properties and targeting key pathways involved in the pathophysiology of hypertension and ischemic cardiomyopathy.

Keywords: CaV1.2 channels; KCa1.1 channels; Langendorff perfused heart; docking simulations; hypertension; labdane; molecular dynamics simulations; sclareolide; vasorelaxant activity.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Labdane diterpenes vasorelaxant agents (14), (+)-sclareolide (5), sclareol (6), and new semi-synthetic tools (710).
Figure 2
Figure 2
Effect of 5 and its derivatives on high KCl-induced contraction and IBa1.2. (A) Concentration-response curves constructed in endothelium-denuded rings pre-contracted by 60 mM KCl. In the ordinate scale, the response is reported as a percentage of the initial tension induced by KCl. Data points represent the mean ± s.e.m. (n = 3–7). (B) Traces of IBa1.2, recorded from a single rat tail artery myocyte, elicited by 250-ms clamp pulses to 10 mV from a Vh of −50 mV, measured in the absence (control) or presence of cumulative concentrations of 7. The block caused by 10 µM nifedipine is also shown. (C) Concentration–response curves constructed in tail artery myocytes. On the ordinate scale, the current amplitude is reported as a percentage of the value recorded just before the addition of the first concentration of each compound. Data points represent the mean ± s.e.m. (n = 5–8).
Figure 3
Figure 3
Current–voltage relationships of IBa1.2 inhibition induced by 5 and its derivatives in single rat tail artery myocytes. (AF) Current-voltage relationships, recorded from a Vh of −50 mV, constructed prior to the addition (control) and in the presence of (A) 100 µM 5, (B) 30 µM 6, (C) 30 µM 10, (D) 30 µM 8, (E) 10 µM 7, and (A) 10 µM 9. Data points are mean ± s.e.m. (n = 5–6). * p < 0.05 vs. control, Student’s t test for paired samples.
Figure 4
Figure 4
Effect of 5 and its derivatives on moderate concentration of KCl- or phenylephrine-induced contractions. (A) Concentration–response curves constructed in endothelium-denuded rings pre-contracted by 25 mM KCl. In the ordinate scale, the response is reported as a percentage of the initial tension induced by KCl. Data points represent the mean ± s.e.m. (n = 3–8). (BE) Concentration–response curves for (B) 5, (C) 8, (D) 7, and (E) 9 constructed in rings either endothelium-denuded or -intact, pre-contracted by 0.3 µM phenylephrine. In the ordinate scale, the response is reported as a percentage of the initial tension induced by phenylephrine (phe). Data points represent the mean ± s.e.m. (n = 5–7).
Figure 5
Figure 5
Effect of 8, 7, and 9 on the voltage dependence of Cav1.2 channel activation and inactivation in single rat tail artery myocytes. Steady-state inactivation curves, recorded from a Vh of −80 mV in the absence (control) or presence of various concentrations of (A) 8, (B) 7, and (C) 9, were fitted to the Boltzmann equation. Peak current values were used. The current measured during the test pulse is plotted against membrane potential and expressed as availability. Steady-state activation curves were obtained from the current–voltage relationships of Figure 3 and fitted to the Boltzmann equation. Data points are mean ± s.e.m. (n = 5–6).
Figure 6
Figure 6
Biophysical and pharmacological features of 7-induced blockade of single rat tail artery myocyte CaV1.2 channels. (A) Effect of 7 on IBa1.2 kinetics. Time constant for activation (τact) and inactivation (τinact) measured in the absence or presence of different concentrations of 7 from a Vh of either −50 mV or −80 mV. Columns represent the mean ± s.e.m. (n = 5–7). * p < 0.05 vs. control, repeated measures ANOVA and Dunnett’s post-hoc test. (B) Effect of membrane potential and Bay K 8644 on IBa1.2 inhibition induced by various concentrations of 7. IBa1.2, elicited by 250-ms clamp pulses to 10 mV from a Vh of either −50 mV (in the absence or presence of 100 nM Bay K 8644) or −80 mV, measured after the addition of cumulative concentrations of 7. The concentration–response curve to 7 at a Vh of −50 mV is taken from Figure 2C. On the ordinate scale, the current amplitude is reported as a percentage of the value recorded just before the addition of the first concentration of the compound. Data points represent the mean ± s.e.m. (n = 5–7). * p < 0.05 vs. control, repeated measures ANOVA and Dunnett post-hoc test.
Figure 7
Figure 7
Effects of 7 on KCa1.1 channels. (A) Average traces (recorded from five cells) of IKCa1.1 measured in tail artery myocytes, in the absence (control) or presence of various concentrations of 7. IKCa1.1 was elicited with a clamp pulse to 70 mV from a Vh of −40 mV, delivered every 10 s. (B) Effect of 7 on the current–voltage relationship. On the ordinate scale, IKCa1.1 amplitude is reported in pA/pF. Data points are mean ± s.e.m. (n = 5). * p < 0.05 vs. control, repeated measures ANOVA and Dunnett post-hoc test.
Figure 8
Figure 8
Effect of Bay K 8644 and TEA on the vasorelaxant activity of 7. (A) Control rings were stimulated by 60 mM KCl, or rings were pre-incubated with (B) 100 nM Bay K 8644 alone or (C) Bay K 8644 plus 10 mM TEA for 10 min, and were stimulated using 10–15 mM KCl. After a steady contraction was obtained, 7 was added cumulatively. (D) Concentration–response curve to 7. In the ordinate scale, the response is reported as a percentage of the initial tension. Data points represent the mean ± s.e.m. (n = 6–7). * p < 0.05 vs. control, repeated measures ANOVA and Dunnett post-hoc test vs. control.
Figure 9
Figure 9
Root mean square deviation (RMSD) profiles of compounds in complex with the CaV1.2 channel, and overview of the channel binding pocket docked with 5, 7, and 9. (AD) The CaV1.2 channel 3D structure is depicted in a multicolor cartoon. The bilayer is depicted as grey lines, while some phospholipid heads are reported in purple spheres. Interaction network of (B) 5, (C) 7 and, (D) 9 in complex with the CaV1.2 binding residues after the docking simulation. The residues involved in π-stacking and hydrogen bonds are reported as red and blue ball/sticks, respectively. The hydrogen atoms are hidden for clarity. (E) RMSD profiles of CaV1.2 channel backbone in complex with 5, 7, and 9. The RMSD trends are represented as colored lines (see legend). The RMSD (nm) and time (ns) values of the MD run are reported on the Y- and X- axis, respectively.
Figure 10
Figure 10
Overview of the KCa1.1 channel binding pocket in complex with 7 and 9. (A) The KCa1.1 channel 3D structure is depicted in the cyan transparency surface and cartoon. Interaction network of (B) 7 and (C) 9 in complex with the KCa1.1 channel binding residues. The residues involved in π-stacking, hydrogen bond, and salt bridge, are reported as red, blue, and orange ball/sticks, respectively. The hydrogen atoms are hidden for clarity.
Figure 11
Figure 11
Effects of compound 7 on LVP and CPP in Langendorff-perfused rat hearts. Concentration–effect relationship of compound 7 on LVP and CPP. On the ordinate scale, the response is reported as mmHg. Each value represents mean ± s.e.m. (n = 5). * p < 0.05, ** p < 0.01 vs. CTRL, repeated measures ANOVA and Dunnett’s post-test.
Figure 12
Figure 12
Original ECG trace recorded under (A) control conditions and (B) in the presence of 30 µM 7.

Similar articles

Cited by

References

    1. Oparil S., Acelajado M.C., Bakris G.L., Berlowitz D.R., Cífková R., Dominiczak A.F., Grassi G., Jordan J., Poulter N.R., Rodgers A., et al. Hypertension. Nat. Rev. Dis. Prim. 2018;4:18014. doi: 10.1038/nrdp.2018.14. - DOI - PMC - PubMed
    1. Tang F., Yan H.L., Wang L.X., Xu J.F., Peng C., Ao H., Tan Y.Z. Review of Natural Resources With Vasodilation: Traditional Medicinal Plants, Natural Products, and Their Mechanism and Clinical Efficacy. Front. Pharmacol. 2021;12:1–24. doi: 10.3389/fphar.2021.627458. - DOI - PMC - PubMed
    1. Carullo G., Mazzotta S., Koch A., Hartmann K.M., Friedrich O., Gilbert D.F., Vega-Holm M., Schneider-Stock R., Aiello F. New oleoyl hybrids of natural antioxidants: Synthesis and in vitro evaluation as inducers of apoptosis in colorectal cancer cells. Antioxidants. 2020;9:1077. doi: 10.3390/antiox9111077. - DOI - PMC - PubMed
    1. Carullo G., Sciubba F., Governa P., Mazzotta S., Frattaruolo L., Grillo G., Cappello A.R., Cravotto G., Di Cocco M.E., Aiello F. Mantonico and pecorello grape seed extracts: Chemical characterization and evaluation of in vitro wound-healing and anti-inflammatory activities. Pharmaceuticals. 2020;13:97. doi: 10.3390/ph13050097. - DOI - PMC - PubMed
    1. Mazzotta S., Governa P., Borgonetti V., Marcolongo P., Nanni C., Gamberucci A., Manetti F., Pessina F., Carullo G., Brizzi A., et al. Pinocembrin and its linolenoyl ester derivative induce wound healing activity in HaCaT cell line potentially involving a GPR120/FFA4 mediated pathway. Bioorg. Chem. 2021;108:104657. doi: 10.1016/j.bioorg.2021.104657. - DOI - PubMed